Episode 510: ADCs in Prostate Cancer

Episode 510: ADCs in Prostate Cancer

Up next

Episode 514: Artificial Intelligence in Cancer Drug Development

Travis Zack, CMO of Open Evidence, joins Brian and Tom to discuss the emergence of AI across the spectrum on cancer, drug development and application of data. 

Episode 513: Trials and Tribulations of Investigator-initiated Research

Bishoy Faltas joins Brian and Tom to discuss his IIT in bladder cancer. The intended discussion of the trials turned into an insightful discussion on the challenges and learning opportunities of IITs. 

Recommended Episodes

Cancer and Exercise - Let’s beat it together. EP #563
BJSM Podcast

In this episode Dr Kyle Winik is joined by Dr Lervasen Pillay, a Sport and Exercise Physician who has a keen interest in Exercise and Cancer. Through the episode they discuss an approach to a patient battling cancer and try to give an approach to change the narrative that exercis ...  Show more

Beating Prostate Cancer
Nutrition Facts with Dr. Greger

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ...  Show more

S7 E3: Anti-Ds side effects; knee OA exercise; PSA trends & PCUK interview with Dr Bunmi Olajide & Kevin Howell
NB Hot Topics Podcast

Welcome back to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research and have a special interview in conjunction with Prostate Cancer UK. First, do antidepressants have physiological side effects? How do they compare ...  Show more

Episode 201 -- March 2024 -- Part 1 AFP: American Family Physician
AFP: American Family Physician Podcast

Thiazide diuretics (2:20), pancreatic cancer (4:40), DermTech pigmented lesion assay (8:30), chronic low back pain (17:00), hearing aids (23:40), and blood pressure cuff size (27:50).